Author: OurCrowd

[Dandelion Energy in Electrek] Dandelion Energy expands residential geothermal to Vermont

Renewable resources provided 99.9% of Vermont’s electricity generation in 2019, the largest share for any state, but it has more than 100,000 homes that use fuel oil, the dirtiest fuel for home heating. US residential geothermal company Dandelion Energy wants to help Vermont ditch the fuel oil – it today announced that it’s expanding its services into the Green Mountain State. Read...

Read More

[Dandelion Energy in PR Newswire] Dandelion Energy Expands Geothermal Heating & Cooling Service to Vermont

BENNINGTON, Vt., May 20, 2021 /PRNewswire/ — Dandelion Energy, the country’s leading residential geothermal company, is expanding sales and service to Vermont. The expansion is supported by new incentives offered by Green Mountain Power (GMP) that provide a rebate worth thousands of dollars when they purchase and install a qualified geothermal whole-home heating and cooling system from Dandelion Energy. Dandelion’s initial entry will be serving customers in southern Vermont’s Bennington County, with plans to expand in the future, providing consultations, planning, installation and service for their heating and cooling systems. Dandelion’s highly efficient system is fossil-fuel-free and combats the second-largest source of carbon pollution in Vermont. Read...

Read More

[Insightec in The Hippocratic Post] Non-invasive brain cancer treatment targeting glioblastoma

A non-invasive Brain Cancer Treatment has been announced by Ivy Brain Tumor Center, SonALAsense and Insightec: The First Patient Dosed in First-in-Human Clinical Trial of Non-invasive Sonodynamic Therapy for the Treatment of Brain Cancer. The study combines metabolic targeting of glioblastoma with inert drug activated using MRI-guided focused ultrasound. Read more...

Read More

[CytoReason in The Times of Israel] Swiss pharma firm Ferring, Israel’s CytoReason join to battle bowel disease

CytoReason, an Israeli startup that uses artificial intelligence to build digital models of the human immune system and diseases to speed up drug development, said Wednesday it will collaborate with Ferring Pharmaceuticals, a Swiss multinational biopharmaceutical company, to find new treatments for patients with inflammatory bowel disease (IBD). Read...

Read More